[1] |
GAO X, JIA Y, XU H, et al. Association between serum pepsinogen and atherosclerotic cardiovascular disease[J]. Nutr Metab Cardiovasc Dis, 2021, 31(1):169-177.
DOI
PMID
|
[2] |
TONG Y, WANG H, ZHAO Y, et al. Serum pepsinogen levels in different regions of China and its influencing factors:a multicenter cross-sectional study[J]. BMC Gastroenterol, 2021, 21(1):264.
DOI
|
[3] |
WANG Y, ZHU Z, LIU Z, et al. Diagnostic value of serum pepsinogen Ⅰ,pepsinogen Ⅱ,and gastrin-17 levels for population-based screening for early-stage gastric cancer[J]. J Int Med Res, 2020, 48(3): 300060520914826.
|
[4] |
KIM D B, JO I H, PAIK C N, et al. Serum pepsinogen and gastrin levels:reliable markers to predict small intestinal bacterial overgrowth[J]. Turk J Gastroenterol, 2022, 33(3):213-220.
DOI
URL
|
[5] |
ZHAO B, ZHANG M, LIU D, et al. Establishment of reference interval for the tumour marker serum CYFRA 21-1 in healthy Chinese Han ethnic adults[J]. Scand J Clin Lab Invest, 2018, 78(3):171-174.
DOI
PMID
|
[6] |
XU P, ZHOU Q, XU J. Reference interval transference of common clinical biomarkers[J]. Scand J Clin Lab Invest, 2021, 81(4):264-271.
DOI
URL
|
[7] |
吴群, 沈隽霏, 吴文浩, 等. 间接法建立总胆红素和直接胆红素参考区间的探讨[J]. 检验医学, 2020, 35(8):749-752.
DOI
|
[8] |
Clinical and Laboratory Standards Institute. Defining, establishing, and verifying reference intervals in the clinical laboratory[S]. EP28-A3c,CLSI, 2010.
|
[9] |
QI Z, ZHANG L, CHEN Y, et al. Biological variations of seven tumor markers[J]. Clin Chim Acta, 2015, 450:233-236.
DOI
PMID
|
[10] |
CHIANG T H, CHEN Y N, CHEN Y R, et al. Brand interchangeability of pepsinogen tests in the real-world setting after eradication of Helicobacter pylori:a community-based study[J]. BMC Gastroenterol, 2022, 22(1):69.
DOI
|
[11] |
GRAD C, POP A, GABOREAN E, et al. Value of GastroPanel in the diagnosis of atrophic gastritis[J]. Exp Ther Med, 2021, 22(5):1347.
DOI
PMID
|
[12] |
金鑫, 李树锦, 陈贞, 等. 血清胃蛋白酶原对幽门螺杆菌感染的诊断价值[J]. 检验医学, 2020, 35(8):791-794.
DOI
|
[13] |
唐伟, 李琳, 赵全能, 等. 南充地区汉族健康人群血清胃蛋白酶原和胃泌素-17参考区间调查研究[J]. 检验医学与临床, 2021, 18(10):1361-1364.
|
[14] |
汪杨, 李溪, 梁志伟, 等. 广州地区健康人群胃蛋白酶原参考范围的建立[J]. 检验医学与临床, 2020, 17(4):433-435.
|